89 related articles for article (PubMed ID: 1705748)
21. The association of human papillomavirus type 16 E6 and E7 antibodies with stage of cervical cancer.
Fisher SG; Benitez-Bribiesca L; Nindl I; Stockfleth E; Muller M; Wolf H; Perez-Garcia F; Guzman-Gaona J; Gutierrez-Delgado F; Irvin W; Gissmann L
Gynecol Oncol; 1996 Apr; 61(1):73-8. PubMed ID: 8626121
[TBL] [Abstract][Full Text] [Related]
22. Detection of antibodies to L1, L2, and E4 proteins of human papillomavirus types 6, 11, and 16 by ELISA using synthetic peptides.
Le Cann P; Chabaud M; Leboulleux D; Mougin C; Mayelo V; Legrand MC; Calvet C; Afoutou JM; Coll-Seck AM; Coursaget P
J Med Virol; 1995 Apr; 45(4):410-4. PubMed ID: 7545211
[TBL] [Abstract][Full Text] [Related]
23. Identification of human papillomavirus seroconversions.
Wikström A; van Doornum GJ; Quint WG; Schiller JT; Dillner J
J Gen Virol; 1995 Mar; 76 ( Pt 3)():529-39. PubMed ID: 7897345
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera.
Rose RC; Reichman RC; Bonnez W
J Gen Virol; 1994 Aug; 75 ( Pt 8)():2075-9. PubMed ID: 8046412
[TBL] [Abstract][Full Text] [Related]
25. Expression of the human papillomavirus type 6b L2 open reading frame in Escherichia coli: L2-beta-galactosidase fusion proteins and their antigenic properties.
Tomita Y; Shirasawa H; Sekine H; Simizu B
Virology; 1987 May; 158(1):8-14. PubMed ID: 2437699
[TBL] [Abstract][Full Text] [Related]
26. Predominance of serum antibodies to synthetic peptide stemming from HPV 18 open reading frame E2 in cervical adenocarcinoma.
Lehtinen M; Leminen A; Paavonen J; Lehtovirta P; Hyöty H; Vesterinen E; Dillner J
J Clin Pathol; 1992 Jun; 45(6):494-7. PubMed ID: 1320634
[TBL] [Abstract][Full Text] [Related]
27. Epitope mapping of the human papillomavirus type 16 E4 protein by means of synthetic peptides.
Suchánková A; Krchnák V; Vágner J; Hamsíková E; Krcmár M; Ritterová L; Vonka V
J Gen Virol; 1992 Feb; 73 ( Pt 2)():429-32. PubMed ID: 1371544
[TBL] [Abstract][Full Text] [Related]
28. Seroepidemiologic studies of bovine papillomavirus infections.
Pfister H; Huchthausen B; Gross G; zur Hausen H
J Natl Cancer Inst; 1979 Jun; 62(6):1423-5. PubMed ID: 220453
[TBL] [Abstract][Full Text] [Related]
29. Pre- and posttreatment serum antibody responses to HPV 16 E2 and HSV 2 ICP8 proteins in women with cervical carcinoma.
Lehtinen M; Leminen A; Kuoppala T; Tiikkainen M; Lehtinen T; Lehtovirta P; Punnonen R; Vesterinen E; Paavonen J
J Med Virol; 1992 Jul; 37(3):180-6. PubMed ID: 1331306
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic phase antibody response to the human papillomavirus type 16 E2 protein is associated with successful treatment of genital HPV lesions with systemic interferon alpha-2b.
Stellato G; Paavonen J; Nieminen P; Hibma M; Vilja P; Lehtinen M
Clin Diagn Virol; 1997 Feb; 7(3):167-72. PubMed ID: 9126686
[TBL] [Abstract][Full Text] [Related]
31. Seric and local antibodies against a synthetic peptide of HPV16.
Dreyfus M; Baldauf JJ; Ritter J; Obert G
Eur J Obstet Gynecol Reprod Biol; 1995 Apr; 59(2):187-91. PubMed ID: 7657014
[TBL] [Abstract][Full Text] [Related]
32. Use of human papillomavirus type 11 virions in an ELISA to detect specific antibodies in humans with condylomata acuminata.
Bonnez W; Da Rin C; Rose RC; Reichman RC
J Gen Virol; 1991 Jun; 72 ( Pt 6)():1343-7. PubMed ID: 1646276
[TBL] [Abstract][Full Text] [Related]
33. Detection of human serum antibodies that neutralize infectious human papillomavirus type 11 virions.
Christensen ND; Kreider JW; Shah KV; Rando RF
J Gen Virol; 1992 May; 73 ( Pt 5)():1261-7. PubMed ID: 1316943
[TBL] [Abstract][Full Text] [Related]
34. Antibodies to human papillomavirus type-16 in human sera as revealed by the use of prokaryotically expressed viral gene products.
Köchel HG; Sievert K; Monazahian M; Mittelstädt-Deterding A; Teichmann A; Thomssen R
Virology; 1991 Jun; 182(2):644-54. PubMed ID: 1850922
[TBL] [Abstract][Full Text] [Related]
35. Sequence variation in the E7 gene of human papillomavirus type 18 in tumor and non-tumor patients and antibody response to a conserved seroreactive epitope.
ter Meulen J; Schweigler AC; Eberhardt HC; Luande J; Mgaya HN; Müller M; Bleul C; Ulken V; Ikenberg H; Pawlita M
Int J Cancer; 1993 Jan; 53(2):257-9. PubMed ID: 7678831
[TBL] [Abstract][Full Text] [Related]
36. Mapping of linear epitopes of human papillomavirus type 16: the L1 and L2 open reading frames.
Dillner J; Dillner L; Utter G; Eklund C; Rotola A; Costa S; DiLuca D
Int J Cancer; 1990 Mar; 45(3):529-35. PubMed ID: 1689705
[TBL] [Abstract][Full Text] [Related]
37. Characterization of human antibody-reactive epitopes encoded by human papillomavirus types 16 and 18.
Jenison SA; Yu XP; Valentine JM; Galloway DA
J Virol; 1991 Mar; 65(3):1208-18. PubMed ID: 1704924
[TBL] [Abstract][Full Text] [Related]
38. Expression of the full-length products of the human papillomavirus type 6b (HPV-6b) and HPV-11 L2 open reading frames by recombinant baculovirus, and antigenic comparisons with HPV-11 whole virus particles.
Rose RC; Bonnez W; Strike DG; Reichman RC
J Gen Virol; 1990 Nov; 71 ( Pt 11)():2725-9. PubMed ID: 2174962
[TBL] [Abstract][Full Text] [Related]
39. Prospective study on the development of antibodies against human papillomavirus type 6 among patients with condyloma acuminata or new asymptomatic infection.
Wikström A; van Doornum GJ; Kirnbauer R; Quint WG; Dillner J
J Med Virol; 1995 Aug; 46(4):368-74. PubMed ID: 7595415
[TBL] [Abstract][Full Text] [Related]
40. [Studies on the establishment of a method to detect HPV 6b E7-specific antibodies of serum and cervical secretion from patients with condyloma acuminatum and its epidemiological significance].
Zhong XZ; Chen S; Zhu SL; Xue XY; Li WS; Wang LD; Zhang LF
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Feb; 31(2):199-203. PubMed ID: 21215084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
